Variant report
Variant | esv3520041 |
---|---|
Chromosome Location | chr13:38070052-38075450 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565279612 | chr13:38070084-38070085 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs7999882 | chr13:38070090-38070091 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs145339466 | chr13:38070126-38070127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372471188 | chr13:38070130-38070131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189942704 | chr13:38070144-38070145 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530162035 | chr13:38070180-38070181 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs8000201 | chr13:38070215-38070216 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs182628511 | chr13:38070230-38070231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552545877 | chr13:38070280-38070281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377091301 | chr13:38070309-38070310 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142434049 | chr13:38070313-38070314 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs201085508 | chr13:38070321-38070322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11306887 | chr13:38070326-38070327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs398077200 | chr13:38070327-38070328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs398037492 | chr13:38070328-38070329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537007471 | chr13:38070331-38070332 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs578096619 | chr13:38070356-38070357 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550613927 | chr13:38070361-38070362 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188821988 | chr13:38070364-38070365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536000148 | chr13:38070400-38070401 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561423938 | chr13:38070451-38070452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553124827 | chr13:38070469-38070470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs376938856 | chr13:38070514-38070515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73448578 | chr13:38070516-38070517 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs113714033 | chr13:38070519-38070520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550038784 | chr13:38070521-38070522 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4941870 | chr13:38070549-38070550 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs73448579 | chr13:38070576-38070577 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs4941871 | chr13:38070624-38070625 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs569764034 | chr13:38070639-38070640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs140477105 | chr13:38070650-38070651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73180687 | chr13:38070664-38070665 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs73448581 | chr13:38070696-38070697 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs146590428 | chr13:38070699-38070700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs193246908 | chr13:38070700-38070701 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140983698 | chr13:38070732-38070733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs550582516 | chr13:38070747-38070748 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567312842 | chr13:38070831-38070832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs150142223 | chr13:38070832-38070833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73448583 | chr13:38070935-38070936 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs565908065 | chr13:38070977-38070978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566572254 | chr13:38071055-38071056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs73448585 | chr13:38071070-38071071 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs9547912 | chr13:38071135-38071136 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs57125213 | chr13:38071136-38071137 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs59305536 | chr13:38071208-38071209 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs111805551 | chr13:38071229-38071230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574443793 | chr13:38071238-38071239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs61010363 | chr13:38071266-38071267 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs532131644 | chr13:38071348-38071349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Prostate cancer | 21965145 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Monoclonal gammopathy of undetermined significance | 19135901 | CNVD |
Prostate cancer | 19242612 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Melanoma | 18172304 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:38069000-38070800 | Enhancers | Hela-S3 | cervix |
2 | chr13:38069600-38073800 | Weak transcription | NHLF | lung |
3 | chr13:38069800-38070400 | Enhancers | Fetal Muscle Leg | muscle |
4 | chr13:38069800-38073200 | Weak transcription | Osteobl | bone |
5 | chr13:38069800-38075200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr13:38070000-38073600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
7 | chr13:38070000-38075000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr13:38073200-38074200 | Enhancers | Osteobl | bone |
9 | chr13:38073600-38074400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr13:38074200-38076200 | Weak transcription | Osteobl | bone |
11 | chr13:38075000-38076400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr13:38075200-38075400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |